Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| PPAR alpha | 7 | 2023 | 21 | 1.450 |
Why?
|
| Microglia | 10 | 2023 | 64 | 1.400 |
Why?
|
| Gemfibrozil | 6 | 2023 | 20 | 1.120 |
Why?
|
| Mice | 23 | 2023 | 760 | 1.070 |
Why?
|
| Dopaminergic Neurons | 3 | 2023 | 23 | 1.070 |
Why?
|
| Animals | 23 | 2023 | 2092 | 0.900 |
Why?
|
| Protein Deglycase DJ-1 | 1 | 2023 | 4 | 0.770 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 1 | 2023 | 6 | 0.760 |
Why?
|
| Up-Regulation | 5 | 2023 | 89 | 0.700 |
Why?
|
| Parkinson Disease | 2 | 2023 | 314 | 0.610 |
Why?
|
| Interleukin-12 | 4 | 2020 | 17 | 0.600 |
Why?
|
| Gene Expression Regulation | 3 | 2015 | 125 | 0.560 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 4 | 2018 | 46 | 0.540 |
Why?
|
| Receptors, Interleukin-12 | 3 | 2020 | 8 | 0.530 |
Why?
|
| Interleukin-12 Subunit p40 | 3 | 2020 | 11 | 0.510 |
Why?
|
| Oligodendroglia | 2 | 2015 | 12 | 0.480 |
Why?
|
| Cells, Cultured | 9 | 2021 | 275 | 0.480 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 5 | 2020 | 27 | 0.460 |
Why?
|
| Astrocytes | 4 | 2021 | 70 | 0.410 |
Why?
|
| PPAR-beta | 2 | 2015 | 8 | 0.400 |
Why?
|
| Nitric Oxide Synthase Type II | 4 | 2009 | 26 | 0.390 |
Why?
|
| Myelin Sheath | 1 | 2012 | 11 | 0.370 |
Why?
|
| Hypolipidemic Agents | 1 | 2012 | 10 | 0.370 |
Why?
|
| Signal Transduction | 7 | 2021 | 246 | 0.360 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 87 | 0.360 |
Why?
|
| Disease Models, Animal | 6 | 2023 | 338 | 0.350 |
Why?
|
| Mice, Knockout | 5 | 2021 | 170 | 0.300 |
Why?
|
| Lymphotoxin-alpha | 1 | 2008 | 2 | 0.290 |
Why?
|
| Interleukin-12 Receptor beta 1 Subunit | 1 | 2008 | 2 | 0.290 |
Why?
|
| NF-kappa B | 7 | 2023 | 53 | 0.280 |
Why?
|
| Cinnamates | 2 | 2019 | 4 | 0.280 |
Why?
|
| Aspirin | 2 | 2018 | 20 | 0.270 |
Why?
|
| Macrophages, Peritoneal | 2 | 2008 | 7 | 0.270 |
Why?
|
| I-kappa B Proteins | 1 | 2007 | 6 | 0.260 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2007 | 23 | 0.260 |
Why?
|
| Cytokines | 5 | 2023 | 107 | 0.240 |
Why?
|
| Alzheimer Disease | 3 | 2023 | 800 | 0.230 |
Why?
|
| Humans | 12 | 2023 | 12240 | 0.220 |
Why?
|
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 11 | 0.220 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2005 | 95 | 0.200 |
Why?
|
| Protein Subunits | 1 | 2003 | 8 | 0.200 |
Why?
|
| Ascorbic Acid | 1 | 2023 | 25 | 0.190 |
Why?
|
| Molecular Chaperones | 1 | 2023 | 8 | 0.190 |
Why?
|
| Neuroglia | 1 | 2023 | 19 | 0.190 |
Why?
|
| Membrane Glycoproteins | 1 | 2023 | 30 | 0.190 |
Why?
|
| Oxidative Stress | 1 | 2023 | 53 | 0.190 |
Why?
|
| Parkinsonian Disorders | 2 | 2021 | 91 | 0.180 |
Why?
|
| Neuroprotective Agents | 2 | 2021 | 24 | 0.180 |
Why?
|
| Inflammation Mediators | 3 | 2021 | 37 | 0.180 |
Why?
|
| Syzygium | 1 | 2021 | 2 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 5 | 2021 | 205 | 0.170 |
Why?
|
| Peptides | 1 | 2021 | 42 | 0.170 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2021 | 39 | 0.170 |
Why?
|
| Lung | 1 | 2021 | 76 | 0.170 |
Why?
|
| Lysosomes | 2 | 2018 | 13 | 0.170 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2021 | 14 | 0.170 |
Why?
|
| alpha-Synuclein | 1 | 2021 | 59 | 0.160 |
Why?
|
| Cell Line | 4 | 2009 | 150 | 0.160 |
Why?
|
| Brain | 4 | 2021 | 707 | 0.150 |
Why?
|
| MPTP Poisoning | 1 | 2019 | 6 | 0.140 |
Why?
|
| Interleukin-11 | 1 | 2018 | 5 | 0.140 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2018 | 16 | 0.140 |
Why?
|
| Corpus Striatum | 1 | 2019 | 42 | 0.140 |
Why?
|
| Substantia Nigra | 1 | 2019 | 68 | 0.140 |
Why?
|
| HEK293 Cells | 3 | 2023 | 20 | 0.140 |
Why?
|
| Plaque, Amyloid | 1 | 2018 | 45 | 0.140 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2018 | 4 | 0.130 |
Why?
|
| T-Lymphocytes | 2 | 2008 | 50 | 0.130 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2009 | 27 | 0.130 |
Why?
|
| Neurons | 2 | 2015 | 164 | 0.120 |
Why?
|
| PPAR gamma | 2 | 2015 | 9 | 0.120 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 2015 | 7 | 0.120 |
Why?
|
| Food Preservatives | 1 | 2015 | 4 | 0.110 |
Why?
|
| Cinnamomum zeylanicum | 1 | 2015 | 9 | 0.110 |
Why?
|
| Sodium Benzoate | 1 | 2015 | 8 | 0.110 |
Why?
|
| Simvastatin | 1 | 2015 | 7 | 0.110 |
Why?
|
| Nerve Growth Factors | 1 | 2015 | 17 | 0.110 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 22 | 0.110 |
Why?
|
| Protein Binding | 3 | 2021 | 70 | 0.110 |
Why?
|
| RNA, Small Interfering | 2 | 2018 | 45 | 0.110 |
Why?
|
| Memory | 1 | 2015 | 112 | 0.110 |
Why?
|
| RNA, Messenger | 3 | 2018 | 157 | 0.110 |
Why?
|
| Primary Cell Culture | 3 | 2021 | 19 | 0.100 |
Why?
|
| Lipopolysaccharides | 2 | 2018 | 41 | 0.100 |
Why?
|
| Multiple Sclerosis | 2 | 2020 | 32 | 0.090 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2023 | 5 | 0.090 |
Why?
|
| Enzyme Activation | 2 | 2015 | 64 | 0.090 |
Why?
|
| Response Elements | 1 | 2012 | 5 | 0.090 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2023 | 13 | 0.090 |
Why?
|
| Demyelinating Diseases | 1 | 2012 | 7 | 0.090 |
Why?
|
| Nitric Oxide | 2 | 2009 | 36 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 179 | 0.080 |
Why?
|
| Female | 6 | 2021 | 6974 | 0.080 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 16 | 0.080 |
Why?
|
| Serum Albumin | 1 | 2009 | 13 | 0.080 |
Why?
|
| Th17 Cells | 2 | 2020 | 15 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 1 | 2009 | 22 | 0.080 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2008 | 2 | 0.070 |
Why?
|
| DNA, Complementary | 1 | 2008 | 16 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 68 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 2 | 2021 | 40 | 0.070 |
Why?
|
| Myelin Basic Protein | 2 | 2005 | 12 | 0.070 |
Why?
|
| Prions | 1 | 2007 | 2 | 0.070 |
Why?
|
| Androstadienes | 1 | 2007 | 3 | 0.070 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2007 | 4 | 0.070 |
Why?
|
| Poly I-C | 1 | 2007 | 5 | 0.070 |
Why?
|
| RNA, Double-Stranded | 1 | 2007 | 3 | 0.070 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2018 | 13 | 0.060 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 2 | 2005 | 6 | 0.060 |
Why?
|
| Amyloid beta-Peptides | 1 | 2007 | 98 | 0.060 |
Why?
|
| Male | 4 | 2021 | 6815 | 0.060 |
Why?
|
| Inflammation | 2 | 2023 | 124 | 0.060 |
Why?
|
| Nitric Oxide Synthase | 2 | 2003 | 21 | 0.060 |
Why?
|
| Mutation | 2 | 2021 | 175 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2023 | 28 | 0.050 |
Why?
|
| Dimerization | 1 | 2003 | 8 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 23 | 0.050 |
Why?
|
| Virus Internalization | 1 | 2023 | 7 | 0.050 |
Why?
|
| Fruit | 1 | 2023 | 18 | 0.050 |
Why?
|
| Phenylacetates | 1 | 2003 | 2 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2023 | 97 | 0.050 |
Why?
|
| Tyrosine | 1 | 2003 | 10 | 0.050 |
Why?
|
| tau Proteins | 1 | 2023 | 88 | 0.050 |
Why?
|
| Adoptive Transfer | 1 | 2003 | 18 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2003 | 61 | 0.050 |
Why?
|
| Ocimum sanctum | 1 | 2021 | 2 | 0.040 |
Why?
|
| Eugenol | 1 | 2021 | 2 | 0.040 |
Why?
|
| Spices | 1 | 2021 | 2 | 0.040 |
Why?
|
| A549 Cells | 1 | 2021 | 5 | 0.040 |
Why?
|
| Locomotion | 1 | 2021 | 8 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2021 | 12 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 16 | 0.040 |
Why?
|
| Multiple System Atrophy | 1 | 2021 | 22 | 0.040 |
Why?
|
| Cytochrome P-450 CYP2C8 Inhibitors | 1 | 2021 | 2 | 0.040 |
Why?
|
| Lewy Body Disease | 1 | 2021 | 54 | 0.040 |
Why?
|
| Interleukin-23 | 1 | 2020 | 3 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2020 | 90 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2015 | 105 | 0.040 |
Why?
|
| Th1 Cells | 1 | 2018 | 10 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2018 | 27 | 0.040 |
Why?
|
| Organelle Biogenesis | 1 | 2018 | 3 | 0.030 |
Why?
|
| CREB-Binding Protein | 1 | 2018 | 2 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 16 | 0.030 |
Why?
|
| Transfection | 1 | 2018 | 59 | 0.030 |
Why?
|
| Isoquinolines | 1 | 2015 | 10 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 26 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2015 | 28 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2015 | 22 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2015 | 15 | 0.030 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2015 | 5 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2015 | 5 | 0.030 |
Why?
|
| Tretinoin | 1 | 2015 | 8 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2015 | 23 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2015 | 11 | 0.030 |
Why?
|
| Autophagy | 1 | 2015 | 16 | 0.030 |
Why?
|
| Adult | 1 | 2020 | 3557 | 0.020 |
Why?
|
| Castration | 1 | 2005 | 2 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2005 | 6 | 0.010 |
Why?
|
| RNA | 1 | 2005 | 18 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2005 | 29 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2005 | 23 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 33 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2005 | 42 | 0.010 |
Why?
|
| Central Nervous System | 1 | 2005 | 29 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 53 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2005 | 48 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2005 | 63 | 0.010 |
Why?
|
| Sex Factors | 1 | 2005 | 229 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2003 | 4 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 2003 | 6 | 0.010 |
Why?
|
| Phenylbutyrates | 1 | 2003 | 3 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2003 | 15 | 0.010 |
Why?
|
| Transcription Factor RelA | 1 | 2003 | 9 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2003 | 18 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2003 | 55 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2003 | 39 | 0.010 |
Why?
|
| Cell Movement | 1 | 2003 | 42 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2003 | 73 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 75 | 0.010 |
Why?
|
| Acute Disease | 1 | 2003 | 90 | 0.010 |
Why?
|
| Spinal Cord | 1 | 2003 | 46 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 2002 | 9 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 15 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2002 | 62 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2003 | 186 | 0.010 |
Why?
|
| Disease Progression | 1 | 2003 | 290 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 423 | 0.010 |
Why?
|